Response to TB
Response to TB
According to the world health organization (WHO), tuberculosis (TB) is one of the world's most dangerous infections, and HIV/AIDS and become the leading cause of death in humans.
About a quarter of the world population is infected with latent (inactive) tuberculosis (TB), of which 10% - 15% of people will continue to develop active TB.
In 2017, 10 million people suffering from tuberculosis, 3.6 million of whom have not been diagnosed or informed.As we know, better informed, diagnosis, and care will help to narrow the gap.
In recent years, the important drug resistance for the prevention and control of tuberculosis.TB antibiotics susceptibility test (AST) of traditional methods, such as disk diffusion method, may need a long time to get a result, this requires a lot of laboratory infrastructure and training, and have potential biological hazards.Acute pulmonary tuberculosis cases and, therefore, there is still a gap between reported has tuberculosis cases.
The United Nations for the sustainable development of the 2030 target, one of the specific goals is "to ensure that all people in all age groups can live a healthy life and promote their well-being".This includes the end tuberculosis epidemic, which needs a global effort.
This effort will begin to address the rise of multi-drug resistant TB strains.Rapid diagnosis and treatment of multi-drug resistant infection is very important to prevent the spread of TB death and disease.
Brooke effort against tuberculosis, in order to help the United Nations to achieve its sustainable development goal.
World TB day in 2019, we launched a major innovation in the field of tuberculosis diagnosis.The new test (based on PCR FluoroType MTBDR 2.0 test) can identify TB pathogen in 3 hours, as well as the important characteristics of antibiotic resistance.It can also by detecting TB of 60 kinds of mutations, found that more than 500 kinds of resistance pattern, and provide related information to guide treatment, thus found mdr-tb.
This level of gene specificity only through sequencing before long and complex ways to implement.
We in government departments, the education department of public health, social welfare organizations, patients, high-risk communities, public health, trust and cooperation between technology vendors will support global drug-resistant TB treatment.
For more information on a global health problem and see who put an end to the strategy of tuberculosis.